EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EA Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10613
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd, is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies for the treatment of gastrointestinal and metabolic diseases. Its pipeline products are used for ulcerative colitis, osteoporosis and chronic constipation diseases. EA Pharma provides drug discovery, production and logistics, sales and marketing, and research and development services. The organization serves various sectors such as medical and healthcare. It markets its products through its network of distributors. EA Pharma is headquartered in Tokyo, Japan.

EA Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EA Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
EA Pharma Enters into Collaboration Agreement with Keio University, Tokyo Medical and Dental University, Kitasato University, Nagoya City University, Kagoshima University and KAN Research Institute 11
EA Pharma and Mochida Pharma Enter into Joint Development Agreement 13
EA Pharma Enters into Co-Promotion Agreement with AbbVie 14
Ajinomoto Pharma and Mochida Pharma Enter into Co-Development Agreement 15
Kissei Pharma Enters into Co-Development Agreement with Ajinomoto Pharma 16
RaQualia Pharma Enters into Research Agreement with Ajinomoto Pharma 17
Licensing Agreements 18
Tasly Pharma Enters into Licensing Agreement with EA Pharma 18
EA Pharma to Enter into Licensing Agreement with Cosmo Technologies 19
JW Pharma Enters into Licensing Agreement with EA Pharma 20
EA Pharma Enters into Licensing Agreement with Calypso Biotech 21
LTT Bio-Pharma Enters into License Agreement with Ajinomoto Pharma 22
Ajinomoto Pharma Amends Licensing Agreement with Albireo for Elobixibat 23
Accellta Enters into Licensing Agreement with Ajinomoto 24
Ildong Enters Into Licensing Agreement With Ajinomoto Pharma For Cilnidipine/Valsartan Drug 25
EA Pharma Co Ltd – Key Competitors 26
EA Pharma Co Ltd – Key Employees 27
EA Pharma Co Ltd – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Legal and Regulatory 29
Mar 30, 2018: EA Pharma Obtained “Marketing License for Medical Devices” 29
Product News 30
Mar 09, 2018: “LIVACT Granules”-A Branched-chain Amino Acid Formula – Launches in Thailand 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EA Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EA Pharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
EA Pharma Enters into Collaboration Agreement with Keio University, Tokyo Medical and Dental University, Kitasato University, Nagoya City University, Kagoshima University and KAN Research Institute 11
EA Pharma and Mochida Pharma Enter into Joint Development Agreement 13
EA Pharma Enters into Co-Promotion Agreement with AbbVie 14
Ajinomoto Pharma and Mochida Pharma Enter into Co-Development Agreement 15
Kissei Pharma Enters into Co-Development Agreement with Ajinomoto Pharma 16
RaQualia Pharma Enters into Research Agreement with Ajinomoto Pharma 17
Tasly Pharma Enters into Licensing Agreement with EA Pharma 18
EA Pharma to Enter into Licensing Agreement with Cosmo Technologies 19
JW Pharma Enters into Licensing Agreement with EA Pharma 20
EA Pharma Enters into Licensing Agreement with Calypso Biotech 21
LTT Bio-Pharma Enters into License Agreement with Ajinomoto Pharma 22
Ajinomoto Pharma Amends Licensing Agreement with Albireo for Elobixibat 23
Accellta Enters into Licensing Agreement with Ajinomoto 24
Ildong Enters Into Licensing Agreement With Ajinomoto Pharma For Cilnidipine/Valsartan Drug 25
EA Pharma Co Ltd, Key Competitors 26
EA Pharma Co Ltd, Key Employees 27

List of Figures
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EA Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biotest AG (BIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclon …
  • Rural Bank Limited
    Rural Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Rural Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • International Personal Finance plc:企業の戦略・SWOT・財務情報
    International Personal Finance plc - Strategy, SWOT and Corporate Finance Report Summary International Personal Finance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Flowserve Corp (FLS):企業の財務・戦略的SWOT分析
    Flowserve Corp (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bioceptive Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioceptive Inc (Bioceptive) is a medical device company that provides medical devices for a variety of gynaecological procedures. The company offers products such as intrauterine devices, intuitive IUD insertion systems and IUD inserters, among others. Its intrauterine devices offer less tra …
  • Biocon Ltd (BIOCON):企業の財務・戦略的SWOT分析
    Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sanmina Corporation:企業の戦略・SWOT・財務情報
    Sanmina Corporation - Strategy, SWOT and Corporate Finance Report Summary Sanmina Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Weizmann Institute of Science:製薬・医療:M&Aディール及び事業提携情報
    Summary Weizmann Institute of Science (WIS) is a research institute that offers research activities in the field of natural and exact sciences. The institute provides programs that include graduate programs, post graduate programs, scientific research, academic affairs, science education, research a …
  • Indena SpA:企業の戦略的SWOT分析
    Indena SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Entravision Communications Corp (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corp (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enusa Industrias Avanzadas, S.A., S.M.E:企業の戦略的SWOT分析
    Enusa Industrias Avanzadas, S.A., S.M.E - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Compass Diversified Holdings LLC:企業のM&A・事業提携・投資動向
    Compass Diversified Holdings LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compass Diversified Holdings LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Tesla Inc (TSLA):企業の財務・戦略的SWOT分析
    Tesla Inc (TSLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • University of Sheffield:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Sheffield (Sheffield University) is an educational service provider that offers undergraduate, postgraduate, research and certificate programmes. The university offers courses in various fields including arts and humanities, engineering, medicine, dentistry and health; social s …
  • Atlas Iron Ltd:企業の戦略・SWOT・財務情報
    Atlas Iron Ltd - Strategy, SWOT and Corporate Finance Report Summary Atlas Iron Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nucor Corporation:戦略・SWOT・企業財務分析
    Nucor Corporation - Strategy, SWOT and Corporate Finance Report Summary Nucor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sacgasco Ltd (SGC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sacgasco Ltd (Sacgasco), formerly Australian Oil Company Ltd is an energy company that offers conventional oil and gas exploration, development and production across Australia. The company develops and produces clean natural gas in the Sacramento Basin, onshore California. It explores Sacram …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆